Journal article
Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa
- Abstract:
-
Background.
Expand abstract
As antiretroviral therapy (ART) programs in sub-Saharan Africa mature, increasing numbers of persons with human immunodeficiency virus (HIV) infection will experience treatment failure, and require second- or third-line ART. Data on second-line failure and development of protease inhibitor (PI) resistance in sub-Saharan Africa are scarce.
Methods.
HIV-1–infected adults were included if they received >180 days of PI-based second-line ART. We assessed risk fa...
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Ministry of Foreign Affairs of the Netherlands
More from this funder
Embassy of the Kingdom of the Netherlands
More from this funder
Heineken Africa Foundation
More from this funder
Jura Foundation
More from this funder
Expand funders...
Bibliographic Details
- Publisher:
- Oxford University Press Publisher's website
- Journal:
- Journal of Infectious Diseases Journal website
- Volume:
- 214
- Issue:
- 6
- Pages:
- 873-883
- Publication date:
- 2016-07-11
- Acceptance date:
- 2016-05-19
- DOI:
- EISSN:
-
1537-6613
- ISSN:
-
0022-1899
- Source identifiers:
-
699722
Item Description
- Keywords:
- Pubs id:
-
pubs:699722
- UUID:
-
uuid:065438e1-2f79-4667-9265-893404b4d9b6
- Local pid:
- pubs:699722
- Deposit date:
- 2017-06-19
Terms of use
- Copyright holder:
- Boender et al
- Copyright date:
- 2016
- Notes:
- © The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.
If you are the owner of this record, you can report an update to it here: Report update to this record